Editorial: The House takes a much-needed swipe at lowering drug prices
Although lawmakers and President Trump have talked a good game about bringing down prescription drug prices, they've managed to take few, if any, steps toward that goal. Trump's most dramatic proposals - tying the price of certain Medicare drugs to their prices overseas and barring payments from drug manufacturers to middlemen - have either been dropped or held up by internal bickering. And a Senate committee's proposal to rein in drug price hikes, which garnered a rare degree of bipartisan
